Emergent BioSolutions Files to Sell 3.61M Shares of Common Stock for Holders
Emergent BioSolutions (NYSE:EBS) Has Debt But No Earnings; Should You Worry?
Express News | India's Business Standard Reported New Study Claims Mpox Clade La Has Evolved To Spread From Human To Human, Citing October 24 Uploaded Paper On Virologica
Emergent Software Welcomes Industry Leader Marc Kermisch as Chief Technology Officer
Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
and new CEO last year really turned things around. they are the only maker of narcan, the druo that saves lives from opioid overdoses
EZ_money OP : PT at 16
EZ_money OP : everything else is pumped up getting extremely overvalued overbought
sugerine : agree this is a long term hold for me
EZ_money OP sugerine :
EZ_money OP : I'm going to bet this explodes back up probably tomorrow
View more comments...